Immune Response to Seasonal Influenza Vaccine in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Long-term Daclizumab Beta: A Prospective, Open-Label, Single-Arm Study

BACKGROUND: For patients with relapsing-remitting multiple sclerosis (RRMS) undergoing continuous immunomodulatory therapy, understanding whether vaccinations can be performed safely and effectively is important. We tested the immune response to inactivated seasonal influenza vaccine during long-ter...

Full description

Saved in:
Bibliographic Details
Published in:Int J MS Care
Main Authors: Mehta, Lahar, Umans, Kimberly, Ozen, Gulden, Robinson, Randy R., Elkins, Jacob
Format: Artigo
Language:Inglês
Published: The Consortium of Multiple Sclerosis Centers 2017
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5460867/
https://ncbi.nlm.nih.gov/pubmed/28603462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2016-026
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items